KELLERMAN DONALD J 4
4 · Zosano Pharma Corp · Filed Apr 1, 2022
Insider Transaction Report
Form 4
KELLERMAN DONALD J
VP, Clinical Dev & Med Affairs
Transactions
- Sale
Common Stock
2022-03-31$0.21/sh−4,006$842→ 56,331 total
Footnotes (1)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer.